ResearchMoz

Mobile Health (mHealth) - Enhancing Healthcare and Improving Clinical Outcomes

GBI Research
Published Date » 2012-12-14
No. Of Pages » 49

Mobile Health (mHealth) Enhancing Healthcare and Improving Clinical Outcomes

Summary

GBI Research, the leading business intelligence provider, has released its latest research report: Mobile Health (mHealth) Enhancing Healthcare and Improving Clinical Outcomes. The report examines how mHealth, which is the facilitation of health-related information through mobile-enabled technologies, has been applied by the pharmaceutical industry in drug development and by healthcare providers in the developed and emerging economies to improve healthcare services and treatment outcomes.

It looks in detail at the ways in which the pharmaceutical industry has utilized mobile technologies in patient recruitment, compliance and retention of clinical trials, its role in marketing and consumer education and the important developments in drug authentication and post-market surveillance.

The report investigates how the healthcare system has migrated from a paper-based system to an electronic one and the innovative ways in which this can be used enhance the flow of medical information. It assesses the growing use of mobile health apps as reference and diagnostic tools to support decision-making and highlights how mHealth can improve communication between patients and healthcare providers; empowering patients to take a more active role in their health and improving the continuum of healthcare from the clinic to the home.

Lastly, the report examines how mHealth programs in the emerging economies and the developed world can help to bridge the gap within fragmented under-resourced healthcare systems. It highlights how technologies devised for the developed countries are not always suitable for the developing countries and the need for local communities to devise mHealth solutions to address local issues such as infectious diseases (dengue fever, AIDS/HIV and tuberculosis) and high infant and maternal mortality rates.

The report is built using information from primary and secondary research including interviews with experts in the field.

GBI Researchs analysis concludes that mHealth has huge potential to bridge the gap within existing healthcare systems but highlights the significant differences in the rate of adoption of mHealth in the developed world compared to the developing countries due to their existing infrastructures and differing doctor-centric and patient centric approaches to healthcare.

The mHealth alliance has identified five critical areas that need to be addressed if mHealth is to become main stream in global health: evidence building, standards and interoperability, sustainable financing, capacity building and policy. This will only be achieved if all stakeholders (patients, healthcare professionals and providers, pharmaceutical industry, mobile network operators and governments) work together to determine the ways in which mHealth can add value and provide significant advantages over traditional routes of healthcare communication.

Scope

  • Detailed analysis of how the pharmaceutical industry is applying mHealth in clinical trials, marketing and supply chain management
  • Assessment of the e-patient engagement strategies that healthcare providers (medical professional, clinicians pharmacists and health insurers) are adopting to improve communication with patients
  • Exploration of the role of mobile health tools in supporting physicians decision-making and prescribable apps to support patient healthcare requirements
  • Explorations of the key challenges facing the adoption of mHealth in the developed world and emerging economies
  • Case studies of mHealth programs and solutions in trial recruitment, supply chain management, decision support tools, education and awareness programs and many more

Reasons to buy

  • Identify key stakeholders and the role they play in the development of mHealth solutions
  • Understand what mHealth services are available and how and where they are being utilized
  • Learn the barriers to implementation and how these may be overcome
  • Understand current thinking on innovative areas of mHealth and its application by the pharmaceutical industry
  • Identify potential opportunities for mHealth solutions by healthcare providers
  • Explore the current mHealth programs and assess the ways these may be translated in other areas of the world
Table of Contents

1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 6
1.2 List of Figures 6

2 Introduction 7
2.1 What is mHealth? 7
2.2 mHealth Aims 8
2.3 Stakeholder Groups Involved in the Funding and Provision of mHealth 9
2.4 Role of mHealth Technologies in the Pharmaceutical Industry 10
2.5 Key Market Segments in the mHealth Space 10
2.5.1 Mobile Health - Mobile Network Operators 10
2.5.2 Mobile Health - Pharmaceutical Industry 10
2.5.3 Mobile Health - Healthcare Professionals 11
2.5.4 Mobile Health - Healthcare Providers 11
2.5.5 Mobile Health - Consumers 11

3 mHealth in Drug Development 12
3.1 Introduction 12
3.2 Mobile Health in Pharmaceutical R&D 13
3.3 Patient Recruitment in Clinical Trials 14
3.3.1 Case Study: REMOTE (Pfizer) 14
3.3.2 Social Media 14
3.4 Patient Compliance and Retention in Clinical Trials 16
3.5 Safety Data Collection 17
3.6 Consumer Education 18
3.7 Mobile Medical Education 18
3.8 Drug Authentication 19
3.9 Post-market Surveillance 20

4 mHealth in Healthcare 21
4.1 Introduction 21
4.2 Electronic Personal Health Records 21
4.3 Electronic Health Records and Medical Records 22
4.3.1 Electronic Health Records and Observational Studies 22
4.4 Clinical Decision Support Systems 23
4.4.1 Case Study: Epocrates 23
4.5 Mobile Healthcare for Healthcare Providers 24
4.5.1 Prescribable Apps 25
4.5.2 Virtual Consultations 25
4.6 Recent Innovations in Medical Diagnostics 26
4.7 Barriers to mHealth Implementation 27

5 Transforming Healthcare in the Emerging Economies through mHealth 28
5.1 Introduction 28
5.2 Shortage of Medical Resources 29
5.3 Improving the Flow of Health Information 30
5.4 Role of the mHealth Alliance 31
5.5 mHealth Applications in the Emerging Economies 32
5.6 Disease Surveillance 33
5.7 Education and Awareness 35
5.7.1 Mobile Technology for Community Health 35
5.7.2 iTEACH 35
5.8 Healthcare Information Management Systems 37
5.9 Health Financing 38
5.10 Patient Monitoring and Support 38
5.11 Point-of-care Services 40
5.12 Barriers to mHealth Implementation in the Emerging Economies 42
5.13 Overall Conclusions 42

6 Appendix 43
6.1 Acronyms 43
6.2 Bibliography 44
6.3 Terminology 48
6.4 Methodology 48
6.4.1 Primary Research 48
6.4.2 Secondary Research 49
6.5 Contact Us 49
6.6 Disclaimer 49

List of Tables


Table 1: mHealth Disease Surveillance Programs 34
Table 2: mHealth Education and Awareness Programs 36
Table 3: mHealth Health Information Management Systems Programs 37
Table 4: mHealth Patient Monitoring and Support Programs 38
Table 5: mHealth Point-of-care Programs 41

List of Figures


Figure 1: mHealth Services 7
Figure 2: Key Stakeholders in the Provision of Funding to Drive mHealth Forward 9
Figure 3: Potential Application of mHealth by the Pharmaceutical Industry 13
Figure 4: Impact of Social Media on Phase III Recruitment of Diabetic Neuropathy Trial, 2011 15
Figure 5: Exco InTouch Services 16
Figure 6: PharmaSecure Drug Authentication Mobile App 19
Figure 7: Innovative Healthcare Software Platforms 20
Figure 8: Mobile Patient Communication Software 24
Figure 9: Patient Perception of how mHealth will Change Healthcare 28
Figure 10: Cell phone Subscriptions per 100 Inhabitants, 2001-2011 29
Figure 11: mHealth Applications in the Emerging Economies 30
Figure 12: mHealth Initiatives in Member States, by WHO region, 2011 32

Upcoming Reports:

Nano-Fiber Cell Scaffold Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018
By - Transparency Market Research
Nano-fiber cell scaffolds are artificial structures used in tissue engineering which provides mechanical, chemical and biological support in tissue formation. Tissue engineering involves the process of growing organs by implantation of engineered tissue from the recipient and thereby preventing immunological rejection which usually occurs in case of organ transplantation. Myocardial tissue engineering (myocardial infarction, ventricular remodeling and heart failure), cartilage repair, bone repair, dermal wound healing and toxicology testing are the application areas where nano-fiber...
Smart Airports Market - Global Industry Analysis, Market Size, Share, Growth, Trends, And Forecast, 2012 - 2018
By - Transparency Market Research
Airport operations and business models have evolved dramatically over the last two decades to support the explosive growth of the global airline industry. Regulatory reform and deregulation ushered in a new aviation era in North America, as well as in Europe, Asia, and in emerging countries, producing dramatic traffic growth, diversity, and choice for airline passengers.  Shifting demographics, new corporate governance requirements, and emerging and maturing communication technologies are driving new travel patterns that will require innovative business models and...
Natural Gas-Fired Electricity Generation Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
By - Transparency Market Research
Demand for power generation has grown immensely with tremendous growth in the world population and the consequent need to fulfill the ever-increasing demands. Fossil fuels are proving insufficient in meeting the increasing demand for energy and hence there is a need to look out for substitute energy resources. Natural gas is the best alternative that can be used for generation of electricity. The natural gas-fired electricity generation market is growing rapidly as it offers a number of advantages over other fossil fuels. Use of gas-fired power generation technology is enhancing...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Top End Stereo Systems Maker Harman Targets Chinese Auto Market
Apr 22, 2014  
Harman, the U.S.-based audio company that is best known as the provider of automobile stereos for top-end car models such as Mercedes-Benz, BMW and Ferrari, has said that it has signed agreements with two leading Chinese automakers—Chang’An and Geely. The company, that is associated with premium infotainment systems for leading auto makers, said that these new contracts...
Scientists Identify Cure for Dengue
Apr 18, 2014  
In a breakthrough discovery that can change the way dengue is treated, scientists have identified a drug target for the deadly dengue viruses. This discovery may help pave the way for discovery of vaccines that can cure this condition that affects nearly 390 million people throughout the world each year.  Scientists have used a new technique for this discovery to show that a region...
India is Facing a Cancer Crisis
Apr 15, 2014  
India is currently facing a cancer crisis – reports a recent research carried out at the King’s college London, in collaboration with the Tata Memorial Cancer Centre, Mumbai.  The reasons estimated for this crisis comprise of increasing rates of smoking, unequal access to proper treatment and belated diagnosis.  Every year, India witnesses around one...
Microparticle Tags to Check Counterfeit Goods Invented
Apr 14, 2014  
Researchers from the Massachusetts Institute of Technology have invented a new set of microparticles that can easily be read by smartphones and establish the authenticity of currency, electronic items and luxury goods.  This strategy is among those countless measures taken by big brands and companies to label their legitimate products in order to stop illegal copies of the...
USFDA Approves Lupins Generic Diabetic Drug
Apr 10, 2014  
The United States Food and Drugs Administration (USFDA) has finally approved Lupin Pharmaceuticals Inc (LPI), the American subsidiary of Indian drug manufacturers Lupin Ltd, to sell Pioglitazone Tablets in the U.S market. The approval has been granted first for fiscal 2015.  Pioglitazone is a generic medicine used for managing diabetes and is a version of Actos tablets...